Katherine Michelle Raab is Vice President of Federal Government Affairs for the Association for Accessible Medicines. As a senior strategist and lobbyist, she represents AAM and its member companies’ interests before Congress and the White House. In this role she develops short- and long-term goals in support of the federal affairs strategy and leads the promotion of AAM’s objectives through advocacy while preserving and enhancing the association’s important relationships on Capitol Hill.
Previously, Katherine was vice president at the Nickles Group, where she represented a variety of health care clients, including established and emerging biopharmaceutical companies. From 2008 to 2017, she served as director of federal government affairs for Genentech. Earlier in her career, Katherine worked in the U.S. House of Representatives’ Counsel for Health Subcommittee and on the legislative staff of three representatives. She earned her MBA from Johns Hopkins and her BA from the University of Richmond.